Search results for "ballo"

showing 10 items of 269 documents

Mechanical circulatory support. An expert opinion of the Association of Intensive Cardiac Care and the Association of Cardiovascular Interventions of…

2021

Mechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart failure, who have exhausted other options for pharmacological or surgical treatments. The purpose of their use is to support, partially or completely, the failed ventricles and ensure adequate organ perfusion, which allows patients to restore full cardiovascular capacity, prolonging their life and effectively improving its quality. The three most popular devices include an intra-aortic balloon pump (IABP), percutaneous assist devices (including Impella, TandemHeart), and venoarterial extracorporeal membrane oxygenation (VA-ECMO). A multidisciplinary approach with the special participation of …

medicine.medical_specialtyPercutaneousmedicine.medical_treatmentShock CardiogenicPsychological interventionventilation and pharmacotherapyPercutaneous Coronary InterventionExtracorporeal membrane oxygenationHumansMedicineIntensive care medicineExpert TestimonyImpellaMechanical ventilationIntra-Aortic Balloon Pumpingbusiness.industryCardiogenic shockmechanical circulatory support-type and extensionmedicine.diseasehemodynamic and echocardiographic monitoringHeart failureConventional PCIindications and complicationsmultidisciplinary approachHeart-Assist DevicesPolandCardiology and Cardiovascular MedicinebusinessKardiologia Polska
researchProduct

Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion.

1999

Activation of Na+/H+ exchange and subsequent calcium overload in cardiac myocytes appear to play an important role in myocardial tissue injury following ischemia and reperfusion. Results of several in vitro studies in isolated myocytes and heart preparations and in vivo studies in pigs and rats have suggested that inhibition of Na+/H+ exchange is an effective means to prevent lethal reperfusion injury, arrhythmia, and improve myocardial contractile dysfunction. In patients with acute myocardial infarction (MI), any preventive agent is administered immediately before or shortly after reperfusion, rather than before the occurrence of coronary occlusion. The direct interventional approach to t…

medicine.medical_specialtySodium-Hydrogen Exchangersmedicine.medical_treatmentPremedicationIschemiaMyocardial InfarctionMyocardial Reperfusion InjuryPilot ProjectsGuanidineschemistry.chemical_compoundInternal medicineAngioplastyLactate dehydrogenasemedicineAnimalsHumansMyocardial infarctionSulfonesAngioplasty Balloon CoronaryInfusions IntravenousCariporidebiologybusiness.industrymedicine.diseaseRatschemistryCoronary occlusionAnesthesiaCardiologybiology.proteinCreatine kinaseCardiology and Cardiovascular MedicinebusinessReperfusion injuryAnti-Arrhythmia AgentsThe American journal of cardiology
researchProduct

Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage

2005

After SAH, primary and secondary complications are frequent and often require neurosurgical interventions to avoid secondary brain damage. The authors of the present paper have summarized the available data about the treatment modalities often used for patients with SAH. The present recommendations have been developed as a neurosurgical and neuroanestesiological consensus. Evidence from prospective, randomized, double blind, placebo-controlled studies support grade A recommendations (standard) for the prophylaxis and treatment of cerebral vasospasm with oral Nimodipine in good grade patients. For intravenous Nimodipine or for oral nimodipine treatment in poor grade patients, available data …

medicine.medical_specialtySubarachnoid hemorrhagemedicine.medical_treatmentNeurosurgeryBrain damageCerebral vasospasmGermanyAngioplastyHypovolemiaHumansVasospasm IntracranialMedicineProspective cohort studyNimodipineRandomized Controlled Trials as Topicbusiness.industrySubarachnoid Hemorrhagemedicine.diseaseSurgeryAnesthesiaSurgeryNeurology (clinical)medicine.symptombusinessHypervolemiaAngioplasty Balloonmedicine.drugNeurochirurgie
researchProduct

Klinische Erfahrungen mit dem Kensey-Katheter-System - Komplikationen und Ergebnisse

1990

Fifteen procedures have been carried out in 14 patients using the Kensey rotation angioplasty system. Sixteen occlusions of the superficial femoral artery, with an average length of 10.2 cm (3 to 24 cm) and one artery with multiple stenoses were treated. The following results were obtained: creation of a lumen, with subsequent balloon dilatation in eight out of fifteen procedures; in two patients the vessels were occluded shortly after the procedure, due to complications (one obstructive plaque and one haematoma); five perforations, three dissections and one peripheral embolus. The total complication rate was 11 out of 15 cases, clinical improvement was obtained in six out of 15 cases.

medicine.medical_specialtySuperficial femoral arterybusiness.industrymedicine.medical_treatmentLumen (anatomy)Balloon dilatationSurgeryCathetermedicine.anatomical_structureAngioplastymedicineRadiology Nuclear Medicine and imagingComplicationbusinessPeripheral EmbolusArteryRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Retrograde recanalization of an in-stent ostial chronically occluded right coronary artery

2010

We describe a case of a chronic proximal in-stent CTO extending up to the ostium of a right coronary artery where successful achievement of guidewire passage through the CTO was performed with a retrograde approach. Guidewire trapping into the right guiding catheter was performed thereafter and procedure was completed by retrograde balloon crossing and antegrade stenting. © 2009 Elsevier Ireland Ltd.

medicine.medical_specialtySurgical approachbusiness.industrymedicine.medical_treatmentStentPCIequipment and suppliesBalloonRetrograde approach.SurgeryCTOOstiumsurgical procedures operativeRight coronary arterymedicine.arteryConventional PCIRetrograde approachGuiding catheterMedicinecardiovascular diseasesRadiologyCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Intracoronary Infusion of Thioflavin-S to Study Microvascular Obstruction in a Model of Myocardial Infarction

2015

Abstract Introduction and objectives Microvascular obstruction exerts deleterious effects after myocardial infarction. To elucidate the role of ischemia-reperfusion injury on the occurrence and dynamics of microvascular obstruction, we performed a preliminary methodological study to accurately define this process in an in vivo model. Methods Myocardial infarction was induced in swine by means of 90-min of occlusion of the mid left anterior descending coronary artery using angioplasty balloons . Intracoronary infusion of thioflavin-S was applied and compared with traditional intra-aortic or intraventricular instillation. The left anterior descending coronary artery perfused area and microvas…

medicine.medical_specialtySwineUltraviolet RaysSus scrofaMyocardial InfarctionLumen (anatomy)Myocardial Reperfusion InjuryAnterior Descending Coronary ArteryCoronary AngiographyBalloonMicrocirculationCoronary CirculationInternal medicineOcclusionPhotographymedicineAnimalsInfusions Intra-ArterialBenzothiazolesMyocardial infarctionFluorescent Dyesbusiness.industryMicrocirculationGeneral Medicinemedicine.diseaseCoronary VesselsDisease Models AnimalThiazolesCoronary OcclusionCoronary occlusionMicrovesselsCardiologybusinessPerfusionRevista Española de Cardiología (English Edition)
researchProduct

Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation.

1998

Background —This study was performed to analyze the influence of either aspirin, ticlopidine, or their combination on platelet activation and aggregation parameters after stent implantation. Methods and Results —Sixty-one patients with successful implantation of a single Palmaz-Schatz stent in a native coronary artery were randomly assigned to either group A (aspirin 300 mg/d+ticlopidine 2×250 mg/d), group B (ticlopidine 2×250 mg/d), or group C (aspirin 300 mg/d). Platelet activation was evaluated on days 1, 7, and 14 by flow cytometry measurement of expression of CD62p (p-selectin) and the binding of fibrinogen to the platelet surface glycoprotein IIb/IIIa receptor. Platelet aggregation w…

medicine.medical_specialtyTiclopidineTime FactorsPlatelet Aggregationmedicine.medical_treatmentUrologyCoronary DiseasePlatelet Glycoprotein GPIIb-IIIa ComplexFibrinogenPhysiology (medical)MedicineHumansPlateletPlatelet activationTiclopidineAngioplasty Balloon CoronaryAspirinChemotherapyAspirinbusiness.industryStentFibrinogenP-SelectinAnesthesiaPlatelet aggregation inhibitorDrug Therapy CombinationStentsCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugCirculation
researchProduct

Decline in the number of coronary angiography and percutaneous coronary intervention procedures in patients with acute myocardial infarction in Polan…

2020

medicine.medical_specialtyTime FactorsCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentPneumonia ViralMyocardial InfarctionCoronary AngiographyPercutaneous Coronary InterventionInternal medicineAngioplastyPandemicmedicineHumansIn patientMyocardial infarctionDisease management (health)Angioplasty Balloon CoronaryPandemicsbusiness.industryPercutaneous coronary interventionCOVID-19Disease Managementmedicine.diseasePneumoniaCardiologyPolandCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsKardiologia polska
researchProduct

Coronary stent implantation in acute vessel closure 48 hours after an unsatisfactory coronary angioplasty

1990

We report the implantation of a balloon-expandable stent in a patient with acute vessel closure in the state of evolving myocardial infarction following 48 hr after unsatisfactory coronary angioplasty. The stent was implanted after successful recanalization of an occluded left anterior descending artery, with repeated unsatisfactory results of balloon angioplasty. Adjunct thrombolytic therapy was contraindicated. No residual stenosis was documented in immediate control angiograms, or after 24 hr, 3 weeks, and 4 months.

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentCoronary DiseaseCoronary AngiographyBalloonAngioplastyInternal medicineCoronary stentmedicineHumansAngina Unstablecardiovascular diseasesMyocardial infarctionAngioplasty Balloon Coronarybusiness.industryStentResidual stenosisMiddle Agedmedicine.diseaseCoronary VesselsSurgerymedicine.anatomical_structureCardiologyStentsCardiology and Cardiovascular MedicineComplicationbusinessArteryCatheterization and Cardiovascular Diagnosis
researchProduct

Nonroutine Use of Intra-Aortic Balloon Pump in Cardiogenic Shock Complicating Myocardial Infarction With Successful and Unsuccessful Primary Percutan…

2018

Abstract Objectives The authors sought to compare outcomes of patients with myocardial infarction and cardiogenic shock (CS) treated with percutaneous coronary intervention (PCI) with or without intra-aortic balloon pump (IABP) support according to final epicardial flow in the infarct-related artery. Background A routine use of IABP is contraindicated in patients with myocardial infarction and CS. There are no data regarding the subpopulation of patients who may benefit from such support besides patients with mechanical complications of myocardial infarction. Methods Prospective nationwide registry data of patients with myocardial infarction and CS treated with PCI between 2003 and 2014 wer…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentShock Cardiogenicprimary PCI030204 cardiovascular system & hematology03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineRisk FactorsInternal medicinemedicineHumansProspective StudiesRegistriescardiovascular diseases030212 general & internal medicineMyocardial infarctionIABPNon-ST Elevated Myocardial InfarctionIntra-aortic balloon pumpIntra-Aortic Balloon Pumpingbusiness.industryCardiogenic shockHazard ratiocardiogenic shockPercutaneous coronary interventionRecovery of FunctionThrombolysismedicine.diseaseTreatment Outcomesurgical procedures operativemyocardial infarctionConventional PCICardiologyST Elevation Myocardial InfarctionPolandCardiology and Cardiovascular MedicinebusinessTIMIJACC-Cardiovascular Interventions
researchProduct